Press Release
Best in Class: Scottsdale Wound Management Guide
Comprehensive pocket handbook offers differential diagnosis and treatment options at your fingertips
Malvern, PA (June 8, 2009) – Proper wound care management has become one of the top concerns for many clinicians across various medical specialties. Treatment is specific to the wound type, the patient and the long-term care plan and requires ongoing assessment. Read More
2008 WOUNDS Article Index
Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
CLINICAL EVENTS CALENDAR
- APMA Annual Scientific MeetingStart Date:July 30, 2009End Date:August 2, 2009
Metro Toronto Convention Centre
Toronto, Canada - Fall Symposium on Advanced Wound Care (SAWC)Start Date:September 16, 2009End Date:September 18, 2009
Gaylord National Hotel and Convention Center
Washington, DC - Wound Clinic BusinessStart Date:June 26, 2009
Hyatt Regency, Orlando International Airport
Orlando, FL - Diabetic Limb Salvage ConferenceStart Date:September 24, 2009End Date:September 26, 2009
Washington, DC
Ortec Partners with PDI for Launch of OrCel into Burn Market
Ortec International, Inc., a tissue-engineering company, announced that it will use a dedicated sales force provided by PDI, a pharmaceutical and medical device and diagnostics sales and marketing company, to target the donor site burn market. OrCel™, a biologically active wound agent, will be launched during the first quarter of 2002 throughout the United States. OrCel is the only product containing living human cells approved by the FDA for healing donor site wounds in burn patients.
Ortec International, Inc., is a tissue-engineering company involved in the commercialization of a proprietary and patented technology to stimulate the repair and regeneration of human tissue. Ortec’s current focus is the application of OrCel to heal chronic and acute wounds. In addition to having received FDA approvals this year for OrCel for treatment of epidermolysis bullosa and donor sites in burn patients, Ortec is also pursuing FDA approvals for venous and diabetic skin ulcers and is in the midst of clinical trials for these indications. Ortec believes that its platform technology extends to the regeneration of other human tissue, such as tendons, ligaments, cartilage, bone, muscle, and blood vessels. For more information, visit www.ortecinternational.com.
- Login or register to post comments
- Email this page
Anytown, California
WOUNDS News Wire
- Thursday, June 18, 2009 - 09:48
- Thursday, June 18, 2009 - 09:44
- Thursday, June 18, 2009 - 09:44
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
![]() Current Concepts In Diagnosing And Treating MRSA In The Diabetic Foot This activity is supported by an education grant from Pfizer. To access this activity, visit www.naccme.com/program/n-528/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
A Complimentary On-Demand CE/CME Webcast This activity is supported by an educational grant from Advanced Biohealing. To access this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |












